(Q30412076)

21 June 2017

1 reference

16 July 2021

Recombinant protein vaccines produced in insect cells (English)

1 reference

21 June 2017

0 references

pharmaceutical science

1 reference

16 July 2021

Manon M J Cox

1

1 reference

PubMed ID

22265860

21 June 2017

language of work or name

English

0 references

publication date

17 January 2012

1 reference

PubMed ID

22265860

21 June 2017

27 February 2012

1 reference

16 July 2021

8

1 reference

inferred from page(s)

published in

Vaccine

2 references

21 June 2017

16 July 2021

30

1 reference

21 June 2017

10

1 reference

21 June 2017

1759-1766

1 reference

Rationalizing the development of live attenuated virus vaccines

21 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Vaccines for viral and parasitic diseases produced with baculovirus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Insect cell technology is a versatile and robust vaccine manufacturing platform

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

On the classification and nomenclature of baculoviruses: a proposal for revision

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Production of Human Beta Interferon in Insect Cells Infected with a Baculovirus Expression Vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

A fast track influenza virus vaccine produced in insect cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

GAD65 vaccination: 5 years of follow-up in a randomised dose-escalating study in adult-onset autoimmune diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Safety and efficacy of a recombinant hepatitis E vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Immunogenicity of hepatitis B surface antigen derived from the baculovirus expression vector system: a mouse potency study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Measles: old vaccines, new vaccines

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

7 January 2021

12 December 2020

Recombinant baculoviruses expressing yellow fever virus E and NS1 proteins elicit protective immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Characterization of tick-borne encephalitis virus-specific human T lymphocyte responses by stimulation with structural TBEV proteins expressed in a recombinant baculovirus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Synthesis of immunogenic hepatitis A virus particles by recombinant baculoviruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Oral vaccination of racoons (Procyon lotor) with baculovirus-expressed rabies virus glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

That Was Then But This Is Now: Malaria Research in the Time of an Eradication Agenda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Human immunodeficiency virus (HIV-1) gp160-specific lymphocyte proliferative responses of mononuclear leukocytes from HIV-1 recombinant gp160 vaccine recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Lymphocyte proliferative responses following immunization with human immunodeficiency virus recombinant GP160. The NIAID AIDS Vaccine Clinical Trials Network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Arbovirus vaccines; opportunities for the baculovirus-insect cell expression system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

New approaches to confronting an imminent influenza pandemic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

A pandemic influenza vaccine in India: from strain to sale within 12 months

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Superior expression of juvenile hormone esterase and beta-galactosidase from the basic protein promoter of Autographa californica nuclear polyhedrosis virus compared to the p10 protein and polyhedrin promoters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Biological activity and field efficacy of a genetically modified Helicoverpa armigera single-nucleocapsid nucleopolyhedrovirus expressing an insect-selective toxin from a chimeric promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Development of a chitinase and v-cathepsin negative bacmid for improved integrity of secreted recombinant proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Enhanced growth of Sf-9 cells to a maximum density of 5.2 x 10(7) cells per mL and production of beta-galactosidase at high cell density by fed batch culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Development of a simple and high-yielding fed-batch process for the production of influenza vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Insect cell culture for industrial production of recombinant proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Use of plant-derived protein hydrolysates for enhancing growth of Bombyx mori (silkworm) insect cells in suspension culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Enhancing the multiplication of nucleopolyhedrovirus in vitro by manipulation of the pH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

An improved in vitro and in vivo Sindbis virus expression system through host and virus engineering.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Improvement of the production of GFPuv-beta1,3-N-acetylglucosaminyltransferase 2 fusion protein using a molecular chaperone-assisted insect-cell-based expression system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Production of inactivated influenza H5N1 vaccines from MDCK cells in serum-free medium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Anthropogenic environmental change and the emergence of infectious diseases in wildlife

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Immunization of colorectal cancer patients with recombinant baculovirus-derived KSA (Ep-CAM) formulated with monophosphoryl lipid A in liposomal emulsion, with and without granulocyte-macrophage colony-stimulating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial Neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Enhanced immune stimulation by a therapeutic lymphoma tumor antigen vaccine produced in insect cells involves mannose receptor targeting to antigen presenting cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

7 January 2021

inferred from DOI database lookup

Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

7 January 2021

inferred from DOI database lookup

Cellular and humoral immune responses to rubella virus structural proteins E1, E2, and C

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.016

7 January 2021

inferred from DOI database lookup

Rotavirus vaccines:an update

1 reference

12 December 2020

Meningococcal vaccines: polysaccharide and polysaccharide conjugate vaccines

1 reference

12 December 2020

Typhoid vaccines: WHO position paper

1 reference

12 December 2020

1 reference

12 December 2020

Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells

1 reference

12 December 2020

Pertussis vaccines: WHO position paper

1 reference

12 December 2020

1 reference

12 December 2020

Evaluation of extracellular subviral particles of dengue virus type 2 and Japanese encephalitis virus produced by Spodoptera frugiperda cells for use as vaccine and diagnostic antigens

1 reference

12 December 2020

Protection against lethal measles virus infection in mice by immune-stimulating complexes containing the hemagglutinin or fusion protein.

1 reference

12 December 2020

Cholera vaccines: WHO position paper

1 reference

12 December 2020

Yellow fever vaccine. WHO position paper

1 reference

12 December 2020

Polio vaccines and polio immunization in the pre-eradication era: WHO position paper

1 reference

12 December 2020

Rubella vaccines: WHO position paper

1 reference

12 December 2020

BCG vaccine. WHO position paper

1 reference

12 December 2020

Vaccines against tick-borne encephalitis: WHO position paper

1 reference

12 December 2020

Japanese encephalitis vaccines

1 reference

12 December 2020

1 reference

12 December 2020

Human papillomavirus vaccines. WHO position paper

1 reference

12 December 2020

Measles vaccines: WHO position paper

1 reference

12 December 2020

1 reference

12 December 2020

WHO position paper on Haemophilus influenzae type b conjugate vaccines. (Replaces WHO position paper on Hib vaccines previously published in the Weekly Epidemiological Record.

1 reference

12 December 2020

Pneumococcal conjugate vaccine for childhood immunization--WHO position paper

1 reference

12 December 2020

Suitability of an E2 subunit vaccine of classical swine fever in combination with the E(rns)-marker-test for eradication through vaccination.

1 reference

12 December 2020

10.1016/J.VACCINE.2012.01.016

Identifiers

DOI

1 reference

21 June 2017

0 references

1 reference

PubMed ID

22265860